Quince director awarded options for 2,700 shares
Quince Therapeutics director David Lamond reported receiving a stock option grant covering 2,700 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Quince Therapeutics director David Lamond reported receiving a stock option grant covering 2,700 shares of common stock. The option has an exercise price of $0.947 per share and expires on June 11, 2036. All 2,700 shares underlying the option will vest in full on the one-year anniversary of the grant date. Following this award, Lamond holds options for 2,700 shares directly.
Insider Trade Summary
Grant/Award: 2,700 shares
Grant/Award
1 txn
Insider
Lamond David
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Director Stock Option (Right to Buy) | 2,700 | $0.00 | $0.00 |
Holdings After Transaction:
Director Stock Option (Right to Buy) — 2,700 contracts (Direct)
Footnotes (1)
- F1. 100% of the shares subject to this stock option will vest on the one-year anniversary of the grant date.
Key Figures
Option shares granted: 2,700 shares
Exercise price: $0.947 per share
Expiration date: June 11, 2036
+2 more
5 metrics
Option shares granted
2,700 shares
Director stock option award to David Lamond
Exercise price
$0.947 per share
Strike price of director stock option
Expiration date
June 11, 2036
Option term end for Lamond’s grant
Underlying common shares
2,700 shares
Common stock covered by the option
Total options after grant
2,700 shares
Total derivative holdings reported following transaction
Key Terms
Director Stock Option (Right to Buy), stock option, exercise price, vesting, +1 more
5 terms
Director Stock Option (Right to Buy) financial
"security_title: "Director Stock Option (Right to Buy)""
stock option financial
"100% of the shares subject to this stock option will vest"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price: "0.9470""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"shares subject to this stock option will vest on the one-year anniversary"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: "2036-06-11T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Quince Therapeutics (QNCX) director David Lamond report?
David Lamond reported receiving a stock option grant for 2,700 shares of Quince Therapeutics common stock. The award is a compensation-related option grant, not an open-market purchase or sale of existing shares.
What is the exercise price of David Lamond’s Quince Therapeutics stock options?
The granted options have an exercise price of $0.947 per share. This means Lamond can buy Quince Therapeutics common stock at $0.947 per share once the options vest and before they expire.
When do David Lamond’s Quince Therapeutics options vest?
One hundred percent of the shares subject to this stock option will vest on the one-year anniversary of the grant date. Vesting must occur before Lamond can exercise the options to acquire the underlying common shares.
When do David Lamond’s Quince Therapeutics stock options expire?
The options expire on June 11, 2036. After that date, Lamond will no longer be able to exercise these options to purchase Quince Therapeutics common stock at the stated exercise price.
Was David Lamond’s Quince Therapeutics transaction an open-market buy or sell?
No, the filing describes a grant or award acquisition of stock options, coded as “A.” This is a compensation-related derivative award, not an open-market purchase or sale of Quince Therapeutics shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates